Article Versions Notes

Shrestha J, Kim SW, Kim S-B, Oh YS, Ki SH, Lee T, Kim S-B, Park T, Baek DJ, Park E-Y. Determining the Anticancer Activity of Sphingosine Kinase Inhibitors Containing Heteroatoms in Their Tail Structure. Pharmaceutics. 2022; 14(1):157. https://doi.org/10.3390/pharmaceutics14010157

Shrestha, Jitendra, Seong Woong Kim, Su-Bin Kim, Yoon Sin Oh, Sung Hwan Ki, Taeho Lee, Sang-Bum Kim, Taeuk Park, Dong Jae Baek, and Eun-Young Park. 2022. "Determining the Anticancer Activity of Sphingosine Kinase Inhibitors Containing Heteroatoms in Their Tail Structure" Pharmaceutics 14, no. 1: 157. https://doi.org/10.3390/pharmaceutics14010157

Shrestha, J., Kim, S. W., Kim, S.-B., Oh, Y. S., Ki, S. H., Lee, T., Kim, S.-B., Park, T., Baek, D. J., & Park, E.-Y. (2022). Determining the Anticancer Activity of Sphingosine Kinase Inhibitors Containing Heteroatoms in Their Tail Structure. Pharmaceutics, 14(1), 157. https://doi.org/10.3390/pharmaceutics14010157